Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.

NCT04216953 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04216953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04216953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Lead sponsor
Centre Leon Berard
Phase
Phase 1/2
Overall status
Completed
Start date
February 12, 2020
Completion date
March 17, 2025
Enrollment
229 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma,soft tissue